Dick's Picks Volume 20

Element Science Announces Completion of Enrollment in the Jewel IDE Study Evaluating the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

Retrieved on: 
Tuesday, May 23, 2023

Element Science , an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced the completion of enrollment in its Jewel IDE Study (NCT05201495).

Key Points: 
  • Element Science , an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced the completion of enrollment in its Jewel IDE Study (NCT05201495).
  • Data from the study will be submitted for U.S. regulatory approval of the Jewel P-WCD to protect patients at temporary elevated risk of sudden cardiac arrest (SCA).
  • “We are grateful to the study participants and clinical research professionals for their commitment and contributions to the Jewel IDE Study.
  • A patient case from the Jewel IDE Study presented at Heart Rhythm 2023 demonstrated the benefits of the Jewel P-WCD and Mobile App.